This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLinked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkEN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLinked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkEN - EnglishSelect a languageLanguagesEN - EnglishFR - FrançiasSearch

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

Menu

Close

AboutAboutCurrent Treatment LandscapeMechanism Of Action (MOA)DosingDosingRecommended dosing scheduleEfficacy & Safety ProfileEfficacy & SafetyAcute Clinical EfficacyPrevention Clinical EfficacySafety and Tolerability ProfileSupporting ResourcesSupport & ResourcesMaterialsVideosOnline Learning

Click here for Vydura® (rimegepant) UK Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

Online Learning Homepage

MigraineDialogues TV is a promotional medical education programme – developed and funded by Pfizer Ltd– intended to support excellence in clinical practice among healthcare professionals involved in the diagnosis, treatment and management of migraine.
 

Migraine Dialogues TV aims to help you achieve the following objectives:
 

  • Improve understanding of diagnosis, management and treatment of migraine at different points of the patient journey
  • Learn about the ongoing challenges and unmet needs in the management of migraine and how innovative treatments could be used in clinical practice
  • Explore how the latest clinical trial data are supporting recommendations to aid decision making in clinical practice
Following the success of Season 1, Exploring the changing landscape of migraine management, Migraine Dialogues TV is back and it is now open access for season 2. This means no registration or logging in is needed to view any of the content.

Hear from Professor Peter Goadsby, Dr David Watson and Dr Richard Wood as we explore clinical trial data and the practical implementation of Vydura in real-world scenarios. Watch the trailer below before visiting MigraineDialoguesTV. Click here to access MDTVLoadingMigraineDialogues TV (MDTV)

Visit MigraineDialogues TV to watch educational materials presented by key opinion leaders and gain CPD points*

*Registration required in order to gain CPD points

Visit MDTV siteLoadingMigraine Therapy Area site

Visit Migraine therapy area site to find out more about diagnosis, patient view, individualised treatment and more around the topic of migraine.

Visit therapy area siteLoading
PP-NNT-GBR-2481. January 2025

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2025 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-11245. January 2025
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​
​
You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​